Quicker blood tests to help diagnose infections

January 2012
Veterinary Ireland Journal;
The article focuses on a study conducted by Amy DeClue, assistant professor of veterinary internal medicine at the University of Missouri, and her colleagues which resulted in the development of a biomarker that will be helpful for the diagnosis of severe infections in animals and humans.


Related Articles

  • theranostics.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2302 

    A definition of the term "theranostics," which refers to the use of diagnostic tests for specific biomakers to determine the patient's reaction to a particular treatment regimen, is presented.

  • Can Procalcitonin Distinguish Sepsis from Other Causes of SIRS? Luks, Andrew M. // Critical Care Alert;Jun2007, Vol. 15 Issue 3, p19 

    Several studies have suggested that procalcitonin may be a useful biochemical marker to differentiate sepsis from other, non-infectious, causes of the systemic inflammatory response syndrome (SIRS), such as pancreatitis. Tang and colleagues conducted a meta-analysis of these studies in order to...

  • Biopsy as well as FibroTest/Fibrosure Is Suboptimal for Discriminating Intermediate Fibrosis Stages in Patients With Chronic Hepatitis B. Munteanu, Mona; Houot, Marion; Ngo, Yen; Poynard, Thierry // American Journal of Gastroenterology;Aug2014, Vol. 109 Issue 8, p1287 

    A letter to the editor is presented in response to the article in the previous issue about the diagnostic accuracy of biochemical marker FibroTest/Fibrosure (FT) in predicting hepatitis B-related fibrosis.

  • Fast answers with new device.  // Canadian Nurse;Mar2012, Vol. 108 Issue 3, p6 

    The author reports a study by researchers at the University of Toronto, who developed a hand-held device to detect low levels of certain cancer biomarkers in about 15 minutes through a blood sample or swab placed on a microchip in the device.

  • PLoS Neglected Tropical Diseases.  // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1 

    The article offers information on the discovery of a biomarker, plasma interleukin-6 which will help in detection of the advanced bile duct fibrosis and bile duct cancer.

  • Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study. Bosco, Cecilia; Wulaningsih, Wahyu; Melvin, Jennifer; Santaolalla, Aida; De Piano, Mario; Arthur, Rhonda; Van Hemelrijck, Mieke // Ecancermedicalscience;2015, Vol. 9 Issue 549-576, p1 

    The Swedish Apolipoprotein MOrtality RISk study (AMORIS) contains information on more than 500 biomarkers collected from 397,443 men and 414,630 women from the greater Stockholm area during the period 1985-1996. Using a ten-digit personal identification code, this database has been linked to...

  • Proceedings of the National Academy of Sciences: Biosignatures distinguish between tuberculosis and sarcoidosis.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article informs that to unequivocally diagnose a specific disease various combinations of biomarkers are required.

  • Blood Test Might Find Infections Faster. Heflin, Marissa // Dog World;Apr2012, Vol. 97 Issue 4, p14 

    The article reports that University of Missouri veterinarian Amy DeClue is working with the Veterinary Diagnostics Institute in developing a portable blood test can diagnose infection in dogs.

  • molecular diagnostics.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1482 

    A definition of the term "molecular diagnostics," which refers to the development and use of biomarkers to diagnose diseases like hematologic and solid cancers, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics